Ep 219 The Tox Talks (Chapter 6): Letybo/Letibotulinum Toxin | Professor Syed Haq

Episode 219 hosts Professor Syed Haq (Cosmetic Physician from London, UK) Syed divides his time between preventative medicine & aesthetics. He has previously been an advisory board member for Ipsen, Allergan Aesthetics and is a Hugel Aesthetics KOL for Letybo.  In this mini series 'The Tox Talks', we feature expert injectors who have significant experience in using botulinum toxins. These episodes explore our guests experiences using particular brands, the evolution of their injecting techniques and we get special insights into the subtle nuances of getting the best out of toxins. In chapter 6 we focus on a newly-launched product called Letybo (Letibotulinum Toxin A), a toxin produced by Hugel Aesthetics. Letybo is also known as Botulax and has been used in the Asian market since 2009.  00:00 Introduction 01:04 Tox Talks Chapter Six Introduction   02:15 New Toxin Release Discussion   03:33 Meet Professor Syed Haq 04:55 Professional Background and Research   09:10 Interest in Skin Aging and Inflammation   10:59 Role as Key Opinion Leader Explained   13:31 Evolution of Neurotoxins in Aesthetics   18:27 Manufacturing and Safety Considerations   21:18 Letybo and Botulax Overview   26:25 Clinical Trial Evidence and Comparisons   30:08 Practical Use and Patient Selection   33:29 Injection Techniques and Variability   36:15 Common Causes of Treatment Differences   38:45 Injection Depth and Needle Choice   40:13 Placebo and Nocebo Effects   41:37 Dosing Strategies and Clinical Patterns   42:46 Frontalis and Lower Face Treatment Doses   47:06 Managing Patient Expectations   48:53 Explaining New Toxins to Patients   52:09 Pricing and Business Considerations   61:45 Unit vs Area Pricing Debate   64:07 Clinical Practice Preferences   68:49 Final Thoughts and Wrap Up ALL IA LINKS & CONTACT INFORMATION